ADI vs. ABBV

Last updated Jun 3, 2026

ADI (Analog Devices, Inc.) and ABBV (AbbVie Inc.) are both stocks. ADI operates in Semiconductors (Technology), while ABBV operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, ADI returned 24.28%/yr vs 17.47%/yr for ABBV. At a 0.26 correlation, their price movements are largely independent.

Performance

ADI vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Analog Devices, Inc. (ADI) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ADI achieves a 56.96% return, which is significantly higher than ABBV's -4.18% return. Over the past 10 years, ADI has outperformed ABBV with an annualized return of 24.28%, while ABBV has yielded a comparatively lower 17.47% annualized return.

ADI

• 1D: 5.38%
• 1M: 6.71%
• YTD: 56.96%
• 6M: 56.50%
• 1Y: 99.97%
• 3Y*: 35.19%
• 5Y*: 23.23%
• 10Y*: 24.28%

ABBV

• 1D: 1.16%
• 1M: 4.26%
• YTD: -4.18%
• 6M: -2.42%
• 1Y: 18.95%
• 3Y*: 20.56%
• 5Y*: 18.28%
• 10Y*: 17.47%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ADI vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ADI Analog Devices, Inc.	56.96%	29.75%	8.82%	23.36%	-4.91%	20.96%	26.87%	41.31%	-1.64%	25.30%
ABBV AbbVie Inc.	-4.18%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%

Correlation

The correlation between ADI and ABBV is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (5Y) Calculated over the trailing 5-year period	0.14
Correlation (10Y) Calculated over the trailing 10-year period	0.22
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013	0.26

Over the past year, the correlation between ADI and ABBV has dropped to 0.05 - well below their long-term average of 0.26, suggesting their price drivers have been diverging.

Fundamentals

Market Cap ADI : $207.56B ABBV : $382.12B
EPS ADI : $6.72 ABBV : $2.05
PE Ratio ADI : 62.97 ABBV : 104.95
PS Ratio ADI : 16.38 ABBV : 6.08
PB Ratio ADI : 6.15 ABBV : 13.90
Total Revenue (TTM) ADI : $12.74B ABBV : $62.82B
Gross Profit (TTM) ADI : $8.22B ABBV : $46.15B
EBITDA (TTM) ADI : $6.19B ABBV : $17.96B

Return for Risk

ADI vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADI

ADI Risk / Return Rank: 94
ADI Sharpe Ratio Rank: 95
ADI Sortino Ratio Rank: 95
ADI Omega Ratio Rank: 93
ADI Calmar Ratio Rank: 94
ADI Martin Ratio Rank: 94

ABBV

ABBV Risk / Return Rank: 62
ABBV Sharpe Ratio Rank: 66
ABBV Sortino Ratio Rank: 59
ABBV Omega Ratio Rank: 58
ABBV Calmar Ratio Rank: 63
ABBV Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADI vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Analog Devices, Inc. (ADI) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ADI	ABBV	Difference
Sharpe ratio Return per unit of total volatility	3.27	0.79	+2.48
Sortino ratio Return per unit of downside risk	4.14	1.25	+2.88
Omega ratio Gain probability vs. loss probability	1.51	1.16	+0.35
Calmar ratio Return relative to maximum drawdown	6.44	1.13	+5.32
Martin ratio Return relative to average drawdown	18.17	2.54	+15.62
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ADI vs. ABBV - Sharpe Ratio Comparison

The current ADI Sharpe Ratio is 3.27, which is higher than the ABBV Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of ADI and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ADI	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.27	0.79	+2.48
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.71	0.80	-0.09
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.75	0.68	+0.06
Sharpe Ratio (All Time) Calculated using the full available price history	0.34	0.73	-0.39

Drawdowns

ADI vs. ABBV - Drawdown Comparison

The maximum ADI drawdown since its inception was -82.88%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ADI and ABBV.

Drawdown Indicators

	ADI	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	-82.88%	-45.09%	-37.79%
Max Drawdown (1Y) Largest decline over 1 year	-15.73%	-17.32%	+1.59%
Max Drawdown (3Y) Largest decline over 3 years	-32.20%	-20.74%	-11.46%
Max Drawdown (5Y) Largest decline over 5 years	-32.20%	-21.92%	-10.28%
Max Drawdown (10Y) Largest decline over 10 years	-33.62%	-45.09%	+11.47%
Current Drawdown Current decline from peak	-1.86%	-9.77%	+7.91%
Average Drawdown Average peak-to-trough decline	-33.94%	-10.73%	-23.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.58%	7.67%	-2.09%

Volatility

ADI vs. ABBV - Volatility Comparison

Analog Devices, Inc. (ADI) has a higher volatility of 12.25% compared to AbbVie Inc. (ABBV) at 5.42%. This indicates that ADI's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ADI	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.25%	5.42%	+6.83%
Volatility (6M) Calculated over the trailing 6-month period	23.60%	17.63%	+5.97%
Volatility (1Y) Calculated over the trailing 1-year period	30.74%	23.95%	+6.79%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.88%	22.84%	+10.04%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.66%	25.74%	+6.92%

Dividends

ADI vs. ABBV - Dividend Comparison

ADI's dividend yield for the trailing twelve months is around 1.22%, less than ABBV's 3.13% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ABBV AbbVie Inc.	3.13%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%
ADI Analog Devices, Inc.	1.22%	1.46%	1.73%	1.73%	1.85%	1.57%	1.68%	1.82%	2.24%	2.02%	2.31%	2.89%

Financials

ADI vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Analog Devices, Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ADI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Analog Devices, Inc. reported a gross profit of 2.44B and revenue of 3.62B. Therefore, the gross margin over that period was 67.3%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

ADI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Analog Devices, Inc. reported an operating income of 1.38B and revenue of 3.62B, resulting in an operating margin of 38.1%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

ADI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Analog Devices, Inc. reported a net income of 1.18B and revenue of 3.62B, resulting in a net margin of 32.5%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.

Frequently Asked Questions

Can I hold both ADI and ABBV in my portfolio?

ADI and ABBV have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ADI or ABBV?

ADI has higher volatility (12.25%) compared to ABBV (5.42%). In terms of maximum drawdown, ADI dropped -82.88% vs ABBV's -45.09%.

Which has better risk-adjusted returns?

ADI currently has the higher Sharpe Ratio (3.27 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.